Esperion Therapeutics Inc (ESPR) Directors and Executive Officers

Officers & Directors

STEPHEN ROCAMBOLI
Director

NICOLE VITULLO
Director

BENJAMIN HALLADAY
Chief Financial Officer (Principal Financial Officer)

ALAN FUHRMAN
Director

SHELDON L. KOENIG
President, Chief Executive Officer and Director (Principal Executive Officer)

SETH H.Z. FISCHER
Director

ANTONIO M. GOTTO, M.D., D. PHIL
Director

TRACY M. WOODY
Director

J. MARTIN CARROLL
Director

JAY SHEPARD
Director ,

Esperion Therapeutics Inc currently has 294 employees.

News about Esperion Therapeutics Inc Key Personnel

Esperion Therapeutics: Navigating a New Financial Horizon Amid Market Uncertainty

As the biotechnology sector continues to navigate the turbulent seas of market volatility, few companies exemplify this challenge like Esperion Therapeutics Inc. (NASDAQ: ESPR). In its latest financial maneuvers, the company has caught the attention of investors and analysts alike with its proactive steps to strengthen its balance sheet. Esperion, focused on developing innovative therapies for cardiovascular diseases, is determined to maintain its footing amid industry fluctuations and investor skepticism.On December 15, 2024, Esperion Therapeutics announced the successful closure of a significant refinancing transaction that may reshape its fiscal landscape. The company secured a $150 million senior secured...